PL2336153T3 - Udoskonalone systemy ekspresji z układem wydzielania SEC - Google Patents

Udoskonalone systemy ekspresji z układem wydzielania SEC

Info

Publication number
PL2336153T3
PL2336153T3 PL10179651T PL10179651T PL2336153T3 PL 2336153 T3 PL2336153 T3 PL 2336153T3 PL 10179651 T PL10179651 T PL 10179651T PL 10179651 T PL10179651 T PL 10179651T PL 2336153 T3 PL2336153 T3 PL 2336153T3
Authority
PL
Poland
Prior art keywords
sec
expression systems
improved expression
system secretion
secretion
Prior art date
Application number
PL10179651T
Other languages
English (en)
Inventor
Diane M Retallack
Jane C Schneider
Thomas Martin Ramseier
Original Assignee
Pfenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfenex Inc filed Critical Pfenex Inc
Publication of PL2336153T3 publication Critical patent/PL2336153T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormones [GH] (Somatotropin)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
PL10179651T 2003-11-21 2004-11-22 Udoskonalone systemy ekspresji z układem wydzielania SEC PL2336153T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52412403P 2003-11-21 2003-11-21
EP04817876A EP1687324B1 (en) 2003-11-21 2004-11-22 Improved expression systems with sec-system secretion
EP10179651.4A EP2336153B1 (en) 2003-11-21 2004-11-22 Improved expression systems with SEC-system secretion

Publications (1)

Publication Number Publication Date
PL2336153T3 true PL2336153T3 (pl) 2016-08-31

Family

ID=34994140

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10179615.9T PL2327718T3 (pl) 2003-11-21 2004-11-22 Ulepszone systemy ekspresyjne z wykorzystaniem systemu sekrecji SEC
PL10179651T PL2336153T3 (pl) 2003-11-21 2004-11-22 Udoskonalone systemy ekspresji z układem wydzielania SEC

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10179615.9T PL2327718T3 (pl) 2003-11-21 2004-11-22 Ulepszone systemy ekspresyjne z wykorzystaniem systemu sekrecji SEC

Country Status (11)

Country Link
US (1) US7985564B2 (pl)
EP (4) EP2336153B1 (pl)
JP (1) JP5028551B2 (pl)
KR (1) KR101265343B1 (pl)
CN (1) CN1882605B (pl)
AU (1) AU2004317306B2 (pl)
BR (1) BRPI0416807A (pl)
CA (1) CA2546157C (pl)
MX (1) MXPA06005705A (pl)
PL (2) PL2327718T3 (pl)
WO (1) WO2005089093A2 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) * 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP2336153B1 (en) 2003-11-21 2016-03-30 Pfenex Inc. Improved expression systems with SEC-system secretion
JP2008507294A (ja) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド 菌株遺伝子操作による改善されたタンパク質発現のための方法
JP5130662B2 (ja) * 2006-06-07 2013-01-30 Jnc株式会社 タンパク質の可溶性タンパク質としての製造方法
EP2468869B1 (en) * 2007-01-31 2015-03-18 Pfenex Inc. Bacterial leader sequences for increased expression
BRPI0810120A2 (pt) 2007-04-27 2014-11-11 Dow Global Technologies Inc Processo para selecionar rapidamente hospedeiros microbianos para a identificação de certas cepas com maior rendimento e/ou qualidade na expressão de proteínas heterólogas
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2009076196A1 (en) 2007-12-07 2009-06-18 Dow Global Technologies Inc. High copy number self-replicating plasmids in pseudomonas
WO2010008764A1 (en) * 2008-06-23 2010-01-21 Dow Global Technologies Inc. Pseudomonas fluorescens strains for production of extracellular recombinant protein
BRPI1015333A2 (pt) 2009-04-17 2016-05-24 Dow Agrosciences Llc "toxinas cry inseticidas dig-3"
ES2663283T3 (es) 2009-12-16 2018-04-11 Dow Agrosciences Llc Uso combinado de las proteínas CRY1Ca y CRY1Fa para el control de insectos resistentes
CA2791361C (en) 2010-03-04 2018-06-12 Pfenex Inc. Method for producing soluble recombinant interferon protein without denaturing
EP2553102B1 (en) 2010-03-30 2015-12-09 Pfenex Inc. High level expression of recombinant toxin proteins
EP2552949B1 (en) 2010-04-01 2016-08-17 Pfenex Inc. Methods for g-csf production in a pseudomonas host cell
NZ603561A (en) 2010-04-23 2015-06-26 Dow Agrosciences Llc Combinations including cry34ab/35ab and cry3aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.)
US9234208B1 (en) 2010-05-10 2016-01-12 Dow Agrosciences Llc DIG-13 insecticidal cry toxins
AR084293A1 (es) 2010-12-16 2013-05-08 Dow Agrosciences Llc Cry1FA RADIOMARCADA, BIOLOGICAMENTE ACTIVA Y METODOS DE ENSAYOS DE UNION AL RECEPTOR
EP2841590A4 (en) * 2012-04-27 2016-03-23 Pronutria Inc NUCLEIC ACIDS, CELLS AND METHODS FOR PRODUCING SECRETED PROTEINS
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN103254277B (zh) * 2013-05-03 2017-02-08 南京工业大学 强分泌性信号肽增强小肽模序及其应用
TW201542093A (zh) 2014-03-21 2015-11-16 艾格里遺傳學股份有限公司 用於控制玉米穗蟲之Cry1D
NZ726117A (en) 2014-06-20 2017-10-27 Dow Agrosciences Llc Vegetative insecticidal proteins useful for control of insect pests
SG11201704362VA (en) 2014-12-01 2017-06-29 Pfenex Inc Fusion partners for peptide production
RU2017122359A (ru) 2014-12-30 2019-01-31 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Модифицированные токсины cryca, применимые для борьбы с насекомыми-вредителями
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
US10889830B2 (en) 2016-09-30 2021-01-12 Dow Agrosciences Llc Binary insecticidal Cry toxins
SG11201909931PA (en) 2017-04-27 2019-11-28 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
AU2018354069A1 (en) * 2017-10-27 2020-06-11 Pelican Technology Holdings, Inc. Bacterial leader sequences for periplasmic protein expression
JP2021500896A (ja) 2017-10-27 2021-01-14 フェネックス インク. 組み換えerwiniaアスパラギナーゼの製造のための方法
CN113528574B (zh) * 2018-08-07 2022-06-21 康码(上海)生物科技有限公司 信号肽相关序列及其在蛋白质合成中的应用
CN112812176B (zh) * 2021-01-13 2022-10-11 江南大学 一种通过低盐絮凝法从螺旋藻中提取藻蓝蛋白的方法
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4595658A (en) 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4513600A (en) 1983-01-03 1985-04-30 The Minster Machine Company Cam actuated ejector for a shell press
GB8308483D0 (en) 1983-03-28 1983-05-05 Health Lab Service Board Secretion of gene products
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4680264A (en) 1983-07-01 1987-07-14 Lubrizol Genetics, Inc. Class II mobilizable gram-negative plasmid
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4637980A (en) 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
EP0155189A3 (en) 1984-03-16 1987-09-16 Genentech, Inc. Expression of cell wall degrading proteins and host cells harboring dna encoding such protein
US4963495A (en) 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
ATE78515T1 (de) 1984-10-05 1992-08-15 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
GB8529014D0 (en) 1985-11-25 1986-01-02 Biogen Nv Enhanced secretion of heterologous proteins
US5232840A (en) * 1986-03-27 1993-08-03 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
AU607209B2 (en) 1987-04-23 1991-02-28 Monsanto Technology Llc Secretion of insulin-like growth factor-i in e. coli
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
AU3751689A (en) 1988-05-09 1989-11-29 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Vector for secretion of proteins directly into periplasm or culture medium
US5169772A (en) 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5175099A (en) * 1989-05-17 1992-12-29 Research Corporation Technologies, Inc. Retrovirus-mediated secretion of recombinant products
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
US5641671A (en) 1990-07-06 1997-06-24 Unilever Patent Holdings B.V. Production of active Pseudomonas glumae lipase in homologous or heterologous hosts
FI913434A (fi) 1990-07-16 1992-01-17 Technical Research Centre F Finland Rekombinanta fusionsproteiner vilka utsoendras.
US5417971A (en) * 1991-10-22 1995-05-23 University Of Saskatchewan Vaccines for Actinobacillus pleuropneumoniae
US5348867A (en) 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5914254A (en) 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US5527883A (en) 1994-05-06 1996-06-18 Mycogen Corporation Delta-endotoxin expression in pseudomonas fluorescens
ATE260979T1 (de) 1994-12-09 2004-03-15 Novo Nordisk As Verfahren zur herstellung extrazellulärer proteine in bakterien
US6495357B1 (en) 1995-07-14 2002-12-17 Novozyme A/S Lipolytic enzymes
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DK1557467T3 (da) * 1996-08-16 2008-09-15 Genencor Int Expressionsystem, der stammer fra lipasereguleringskaskaden i Psedomonas alcalignenes
US6361989B1 (en) * 1997-10-13 2002-03-26 Novozymes A/S α-amylase and α-amylase variants
US6156552A (en) 1998-02-18 2000-12-05 Novo Nordisk A/S Lipase variants
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
US20030064435A1 (en) 1998-05-28 2003-04-03 Weiner Joel Hirsch Compositions and methods for protein secretion
US6323007B1 (en) 1998-09-18 2001-11-27 Novozymes A/S 2,6-β-D-fructan hydrolase enzyme and processes for using the enzyme
DK1124941T3 (da) 1998-10-28 2004-02-02 Genentech Inc Fremgangsmåde til isolering af heterologe polypeptider fra bakterieceller
KR100312456B1 (ko) * 1999-03-13 2001-11-03 윤덕용 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자
AU779814B2 (en) 1999-03-29 2005-02-10 Novozymes A/S Polypeptides having branching enzyme activity and nucleic acids encoding same
US6664386B1 (en) 1999-04-08 2003-12-16 The Research Foundation Of State University Of New York System for efficient secretion of recombinant proteins
US6558939B1 (en) 1999-08-31 2003-05-06 Novozymes, A/S Proteases and variants thereof
DE19944870A1 (de) 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
US6617143B1 (en) 1999-10-20 2003-09-09 Novozymes A/S Polypeptides having glucanotransferase activity and nucleic acids encoding same
US6509181B1 (en) 2000-04-14 2003-01-21 Novozymes, A/S Polypeptides having haloperoxide activity
GB0027782D0 (en) 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods fro large scale protein productio in prokaryotes
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10108212A1 (de) 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
US7419783B2 (en) * 2001-11-05 2008-09-02 Research Development Foundation Engineering of leader peptides for the secretion of recombinant proteins in bacteria
MXPA04007886A (es) 2002-02-13 2004-10-15 Dow Global Technologies Inc Sobre-expresion de genes de extremozimo en pseudomonadas y bacterias estrechamente relacionadas.
AU2003218217A1 (en) 2002-03-15 2003-09-29 The Trustees Of The University Of Pennsylvania Heterologous protein production using the twin arginine translocation pathway
DE60329382D1 (de) 2002-04-22 2009-11-05 Dow Global Technologies Inc Kostengünstige herstellung von peptiden
WO2004005221A2 (en) 2002-07-03 2004-01-15 Dow Global Technologies Inc Benzoate- and anthranilate-inducible promoters
EP2336153B1 (en) 2003-11-21 2016-03-30 Pfenex Inc. Improved expression systems with SEC-system secretion
ES2663594T3 (es) 2004-01-16 2018-04-16 Pfenex Inc Expresión de proteínas de mamífero en Pseudomonas fluorescens
EP2468869B1 (en) * 2007-01-31 2015-03-18 Pfenex Inc. Bacterial leader sequences for increased expression

Also Published As

Publication number Publication date
EP2336153B1 (en) 2016-03-30
JP2007512028A (ja) 2007-05-17
WO2005089093A2 (en) 2005-09-29
EP2327718A1 (en) 2011-06-01
US20060008877A1 (en) 2006-01-12
KR20060123173A (ko) 2006-12-01
CN1882605A (zh) 2006-12-20
EP1687324A2 (en) 2006-08-09
AU2004317306A1 (en) 2005-09-29
BRPI0416807A (pt) 2007-01-09
WO2005089093A3 (en) 2006-03-02
US7985564B2 (en) 2011-07-26
CA2546157C (en) 2014-07-22
JP5028551B2 (ja) 2012-09-19
EP2327718B1 (en) 2016-03-23
EP2314602A1 (en) 2011-04-27
MXPA06005705A (es) 2006-08-23
EP2336153A1 (en) 2011-06-22
EP1687324B1 (en) 2012-08-22
CN1882605B (zh) 2012-07-11
KR101265343B1 (ko) 2013-05-20
CA2546157A1 (en) 2005-09-29
EP1687324A4 (en) 2007-08-22
PL2327718T3 (pl) 2016-10-31
AU2004317306B2 (en) 2010-09-02

Similar Documents

Publication Publication Date Title
EP1687324A4 (en) IMPROVED EXPRESSION SYSTEM WITH SEC SYSTEM SECRETION
ZA200605863B (en) PEF-TU expression units
ZA200605862B (en) PGRO Expression Units
GB2409502B (en) Connection
GB0305873D0 (en) Get into bed - chair
GB0325494D0 (en) Expression system
PL1533429T3 (pl) Połączenie zespolone
GB2406785B (en) The zap-o
GB0304882D0 (en) Polypetide
ZA200603672B (en) 4-biarylyl-1-phenylazetidin-2-ones
GB0302146D0 (en) Hi-Safe systems
GB0326461D0 (en) Stop off
GB0307836D0 (en) The aquadome
GB0329993D0 (en) The quitter
GB0314407D0 (en) The memopage
GB0306818D0 (en) The slumber-bumper
GB0315881D0 (en) The sunwatch
GB0317425D0 (en) The ladderman
GB0319442D0 (en) The bedrite sleeptite
GB0307806D0 (en) The acquaciser
GB0322562D0 (en) The matlight
GB0313665D0 (en) The degravitator
GB0325439D0 (en) The cycirlator
GB0325666D0 (en) The femu
GB0300669D0 (en) The babybath